There's good reason to go after dermatitis in dogs. Apoquel is a leading dermatitis drug for dogs in the US with sales of over $500m a year. Animal blockbusters are catching up to human. But Botanix are too far behind the mark at the moment, Auscann have already submitted the first CBD application for dermatitis in dogs for approval in Australia, just waiting on the tick from regulators. Could be an interesting deal here between the two though..
There's good reason to go after dermatitis in dogs. Apoquel is a...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 410003 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 346713 | 8 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |